The US state of Utah has begun a trial allowing artificial intelligence (AI) to issue initial prescriptions for acne treatment. The AI system, developed by Nolla Health, analyzes images of a patient's face to assess their skin condition and selects a treatment from a list of eight approved options. This new approach has sparked controversy in the healthcare sector. The trial is currently limited to adults with mild to moderate acne.
The AI-powered service, called Nolla Derm, operates through a mobile application. Users upload a photo of their face, which the AI system then evaluates to determine the severity of their acne. Based on this assessment, the AI selects a suitable treatment. The service costs $4.99 per month, with the cost of prescriptions being billed separately. The company aims to handle routine cases and reduce the workload of dermatologists.
Despite the AI-driven approach, human oversight is still in place. For the first 100 cases, a doctor reviews the AI-generated prescription before it is sent to a pharmacy. Subsequently, the first 500 prescriptions are subject to retrospective review, and then a random 10% sample of prescriptions is reviewed monthly. Cases that the AI system cannot handle are referred to a human doctor.
The trial in Utah marks a significant development in the use of AI in healthcare. The AI system does not simply provide health advice; it plays a more substantial role in assessing conditions, selecting treatments, and issuing prescriptions. This could pave the way for broader applications of AI in medical care in the future.
According to Digital Trends, the goal of this initiative is not to replace human doctors but to alleviate their workload by handling routine cases. By freeing up dermatologists' time, the AI system can help reduce waiting times and improve the overall efficiency of healthcare services.
The use of AI in acne treatment has the potential to make healthcare more accessible and affordable. With a monthly subscription fee of $4.99, the service is relatively inexpensive compared to traditional doctor consultations. Additionally, the AI system can help reduce the financial burden on healthcare providers by minimizing the need for in-person consultations.
As the trial progresses, it will be essential to monitor the effectiveness of the AI system and its impact on patient outcomes. The results of this trial could have significant implications for the future of healthcare, potentially leading to the integration of AI into various aspects of medical care.
Key points
- The AI-powered acne treatment service costs $4.99 per month, with prescription costs billed separately.
- Human oversight is in place, with doctor reviews of AI-generated prescriptions and retrospective reviews of a sample of prescriptions.
- The trial aims to handle routine cases and reduce the workload of dermatologists, rather than replacing them.
